Marchés français ouverture 23 min

Laboratory Corporation of America Holdings (LH)

NYSE - Nasdaq Cours en temps réel. Devise en USD
Ajouter à la liste dynamique
240,94+6,58 (+2,81 %)
À la clôture : 04:00PM EDT
240,71 -0,23 (-0,10 %)
Échanges après Bourse : 04:45PM EDT
Connectez-vous pour publier un message.

Tout commentaire contraire à la réglementation en vigueur (et notamment tout commentaire à caractère raciste, antisémite ou diffamatoire) pourra donner lieu à la suppression de votre compte Yahoo.

Le cas échéant, certains commentaires que vous postez pourront également donner lieu à des poursuites judiciaires à votre encontre.

  • a
    alan
    OPKO Health, Inc.
    Earnings report coming tomorrow for $LH. Expecting a blowout quarter, raising the whole sector with it.
  • R
    RAZU
    Meanwhile $DGX & $LH... Let’s just say I’m glad I sold DGX and went on $OPK. I’m already close to 100% return in about a month
  • T
    Tailspin
    $LH conversation
    IMHO, the recent drop to the $124 level just offered an opportunity for a long term BUY. They are growing fast and I don't think they will be this cheap again.
  • R
    RAZU
    So $OPK up 144% since last month. How is $DGX & $LH doing..?

    🤷‍♂️
  • S
    Sherry
    $LH conversation
    Demise of Theranos no great surprise, but removes a potential long term negative.
  • a
    art
    $LH conversation
    S&P Capital NEW LH PRICE TARGET: 12-month target of $155, 15.8X our '17 EPS estimate.
    This multiple is a premium to peers, justified by our above average sales growth outlook.
    ***We raise our '16 and '17 EPS estimates by $0.02 and $0.10 to $8.81 and $9.79.
    LH reported Q3 operating EPS of $2.25 vs $2.07, $0.04. Q3 sales increased 4.5%.
    We expect 10.8% sales growth in '16 aided by pricing improvements due to growth in esoteric test volumes.
  • a
    art
    $LH conversation
    Laboratory Corporation of America® Holdings (LabCorp®) (LH) today announced it will participate at the 2016 Credit Suisse Nov-7th-Healthcare Conference.
    LabCorp’s presentation is planned for Monday, November 7, 2016 at 12:30 PM (ET).
  • S
    Steven
    $LH conversation
    As investors are you at all concerned with the terrible back office at LCA? I've been fighting them through my insurance company for six months on a service that was paid back in January. Labcorp was paid on April 26, 2016 by my insurance but I continue to be billed, in full, for the service. I call my insurance, they confirm payment, then call Labcorp. Labcorp says they will put my billing on hold and will look into it. Then a couple of months later without comment from Labcorp I get another ever escalating invoice/collection notice. This is extremely poor customer service. It seems like my only recourse is to hire an attorney that I can not afford. Maybe there are others out there with the same problem. If so we could start a class action against LCA.
  • a
    art
    $LH conversation
    Last SPLIT was 2002 (2 for 1) -STILL ONLY 100Million Shares outstanding.
    IMHO_ IF another SPLIT is announced-it could be around Dec. 9th--which would be ex-div. date (if Div. was forthcoming)
    IMHO- Theranos Departure from Lab Diagnostics-has helped LH icrease Market Share....
  • a
    art
    $LH conversation
    With Theranos OUT--there is LESS Competition!
  • W
    Will
    Co-Diagnostics, Inc.
    $LH has the testing job for the country not this pump and dump.